the majority of which are ‘glutamatergic’. This means that the presynaptic neuron releases the neurotransmitter glutamate, which crosses the synaptic gap to bind to receptors — usually ...
Glutamatergic medications are a class of drugs that target the glutamate neurotransmitter system in the brain. These medications function by modulating glutamate neurotransmission and receptor ...
These receptors respond to various ligands ... D1R-IP3 signaling leads to adenosine release, which decreases glutamatergic transmission to NAc medium spiny neurons. Mice lacking functional ...
The group focuses on studying the mechanisms guiding activity-dependent development of glutamatergic circuitry in the limbic system and in particular, the roles of ionotropic glutamate receptors in ...
Although compounds with a combined cholinergic–glutamatergic action have been trialed, none has yet been successful in the later stages of development (Table 4). Consequently, combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results